Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Founded in 1995 with approval granted by the State Administration for Industry, the China Capital Investment (Group) Co., Ltd. (‘CCIG’) is registered in Shanghai with a registered capital of CNY300 million. CCIG seeks to optimize its investment structure as well as enhance its economic growth and competitive edge by fully harnessing the opportunities unleashed by changes in the global economic structure and China’s economic transformation. To this end, CCIG focuses on industry investments and capital operations and manages its assets in a professional and investment-centered manner that is at the same time grounded in industry experience. Currently, CCIG involves a number of areas, including mining, healthcare, real estate, cultural tourism, Information Technology, energy, and finance and securities. With a strong asset structure and abundant operational cash flow, CCIG is slated to grow its financial strength, establish more quality investment programs, implement excellent management and tap on a strong pool of professional talents as its assets take more a more international profile.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2015 | Kkeye | Series C | - |
1/2019 | Calterah | Series B | 3M |
1/2015 | Wisharedu | Angel Round | 484.3k |
9/2020 | VitaVitro Biotech | Series C | 15.5M |
5/2020 | Galaxis Automotion | Series D | 14M |
3/2019 | Dingdang Kuaiyao | Series C | 89M |
7/2016 | ASO360 | Angel Round | 449.2k |
7/2015 | Olacio.com | Angel Round | 484.8k |
8/2018 | Blue Pencil | Angel Round | 435.8k |
10/2020 | GeneCast Biotechnology | Series E | - |
5/2018 | Winner&s;s Key | Series A | 3.1M |
10/2018 | Bapingtianxia | Series A | 2.9M |
12/2016 | DREVO | Series A | 1.4M |
4/2014 | Landi English | Angel Round | - |
10/2016 | CAMECO | Post-IPO Equity | 7.4M |
10/2019 | Yunxi Technology | Series B | 49.5M |
2/2021 | Binhui Biotech | Series C | 0 |
10/2018 | Xi Xiang | Series B | 17.3M |
4/2019 | INXX | Series B | 16.5M |
7/2018 | Beijing Allcure Medical Technology | Series B | 103.1M |
2/2021 | Vision Medicals | Series C | 30M |
10/2020 | 3D Medicines | Private Equity Round | 0 |
12/2017 | Learn Education | Series A | - |
1/2019 | Zhangshang Tangyi | Series C | 100M |
10/2019 | AIpark | Series B | - |
1/2021 | WorkTrans | Series D | 140M |
6/2019 | Waterdrop | Series C | 144.6M |
7/2022 | Lihe Weiwei | Series D | - |
12/2016 | Raycloud | Series A | 1.4M |
12/2019 | Baibu | Series D | 0 |
11/2015 | Careyes | Angel Round | 473.5k |
9/2016 | Harvest Wealth Management | Angel Round | 449k |
8/2011 | Xijie | Series A | 12.4M |
1/2018 | Cun Cao Xin | Angel Round | 465.6k |
10/2012 | LIUYANGHE LIQUOR | Angel Round | 479.9k |
2/2017 | Teasoon | Angel Round | 435.9k |
2/2021 | Binhui Biotech | Series C | 0 |
2/2021 | Vision Medicals | Series C | 0 |
1/2021 | WorkTrans | Series D | 0 |
10/2020 | GeneCast Biotechnology | Series E | - |
10/2020 | 3D Medicines | Private Equity Round | 0 |
9/2020 | VitaVitro Biotech | Series C | 0 |
5/2020 | Galaxis Automotion | Series D | 0 |
12/2019 | Baibu | Series D | 0 |
10/2019 | AIpark | Series B | - |
10/2019 | Yunxi Technology | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|